References
- Abdel-Nour M, Carneiro LAM, Downey J, Tsalikis J, Outlioua A, Prescott D, Da Costa LS, Hovingh ES, Farahvash A, Gaudet RG, Molinaro R, van Dalen R, Lau CCY, Azimi FC, Escalante NK, Trotman-Grant A, Lee JE, Gray-Owen SD, Divangahi M, Chen JJ, Philpott DJ, Arnoult D, Girardin SE. The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling. Science 365, eaaw4144, 2019.10.1126/science.aaw414431273097
- Abu Aboud O, Chen CH, Senapedis W, Baloglu E, Argueta C, Weiss RH. Dual and specific inhibition of NAMPT and PAK4 by KPT-9274 decreases kidney cancer growth. Mol Cancer Ther 15, 2119–2129, 2016.10.1158/1535-7163.MCT-16-0197501093227390344
- Acunzo J, Katsogiannou M, Rocchi P. Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol 44, 1622–1631, 2012.10.1016/j.biocel.2012.04.00222521623
- Alaee M, Khaghani S, Behroozfar K, Hesari Z, Ghorbanhosseini SS, Nourbakhsh M. Inhibition of nicotinamide phosphoribosyltransferase induces apoptosis in estrogen receptor-positive MCF-7 breast cancer cells. J Breast Cancer 20, 20–26, 2017.10.4048/jbc.2017.20.1.20537857628382091
- Awais R, Spiller DG, White MR, Paraoan L. p63 is required beside p53 for PERP-Emediated apoptosis in uveal melanoma. Br J Cancer 115, 983–992, 2016.10.1038/bjc.2016.269506190427584665
- Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian BC, Attardi LD. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet 6, e1001168, 2010.10.1371/journal.pgen.1001168295881520975948
- Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Breuss J, Minchenko OH, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Binder BR, Leitinger N. Oxidized phospholipids stimulate angiogenesis via induction of VEGF, IL-8, COX-2 and ADAMTS-1 metalloprotease, implicating a novel role for lipid oxidation in progression and destabilization of atherosclerotic lesions. Circ Res 99, 900–908, 2006.10.1161/01.RES.0000245485.04489.ee16973904
- Bong IP, Ng CC, Fakiruddin SK, Lim MN, Zakaria Z. Small interfering RNA-mediated silencing of nicotinamide phosphoribosyltransferase (NAMPT) and lysosomal trafficking regulator (LYST) induce growth inhibition and apoptosis in human multiple myeloma cells: A preliminary study. Bosn J Basic Med Sci 16, 268–275, 2016.
- Carra S, Boncoraglio A, Kanon B, Brunsting JF, Minoia M, Rana A, Vos MJ, Seidel K, Sibon OC, Kampinga HH. Identification of the Drosophila ortholog of HSPB8: implication of HSPB8 loss of function in protein folding diseases. J Biol Chem 285, 37811–37822, 2010.10.1074/jbc.M110.127498298838520858900
- Cheleschi S, Giordano N, Volpi N, Tenti S, Gallo I, Di Meglio M, Giannotti S, Fioravanti A. A complex relationship between visfatin and resistin and microRNA: An in vitro study on human chondrocyte cultures. Int J Mol Sci 19, E3909, 2018.10.3390/ijms19123909632083230563239
- Chen J, Zhang S, Li Y, Tang Z, Kong W. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumour Biol 35, 3743–3753, 2014.10.1007/s13277-013-1496-224363061
- Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, Xue C, Ren F, Ren Z, Li J, Liu L, Duan Z, Cui G, Sun R. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer 18, 33, 2019.10.1186/s12943-019-0947-9639774630825877
- Chiavarina B, Nokin MJ, Bellier J, Durieux F, Bletard N, Sherer F, Lovinfosse P, Peulen O, Verset L, Dehon R, Demetter P, Turtoi A, Uchida K, Goldman S, Hustinx R, Delvenne P, Castronovo V, Bellahcene A. Methylglyoxal-mediated stress correlates with high metabolic activity and promotes tumor growth in colorectal cancer. Int J Mol Sci 18, pii: E213, 2017.10.3390/ijms18010213529784228117708
- Crippa V, Carra S, Rusmini P, Sau D, Bolzoni E, Bendotti C, De Biasi S, Poletti A. A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases. Autophagy 6, 958–960, 2010a.10.4161/auto.6.7.1304220699640
- Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, Bolzoni E, Galbiati M, Fontana E, Marino M, Carra S, Bendotti C, De Biasi S, Poletti A. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 19, 3440–3456, 2010b.10.1093/hmg/ddq25720570967
- Cui XY, Wang N, Yang BX, Gao WF, Lin YM, Yao XR, Ma XT. HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect. Exp Hematol 40, 14–21, 2012.10.1016/j.exphem.2011.09.00421914495
- Cui D, Sajan P, Shi J, Shen Y, Wang K, Deng X, Zhou L, Hu P, Gao L. MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations. Oncotarget 8, 25345–25361, 2017.10.18632/oncotarget.15867542193528445981
- Feng J, Yan PF, Zhao HY, Zhang FC, Zhao WH, Feng M. Inhibitor of nicotinamide phosphoribosyltransferase sensitizes glioblastoma cells to temozolomide via activating ROS/JNK signaling pathway. Biomed Res Int 2016, 1450843, 2016.10.1155/2016/1450843520641128097126
- Guilbert SM, Lambert H, Rodrigue MA, Fuchs M, Landry J, Lavoie JN. HSPB8 and BAG3 cooperate to promote spatial sequestration of ubiquitinated proteins and coordinate the cellular adaptive response to proteasome insufficiency. FASEB J 32, 3518–3535, 2018.10.1096/fj.201700558RR29405094
- Guo Y, Zhang Y, Yang X, Lu P, Yan X, Xiao F, Zhou H, Wen C, Shi M, Lu J, Meng QH. Effects of methylglyoxal and glyoxalase I inhibition on breast cancer cells proliferation, invasion, and apoptosis through modulation of MAPKs, MMP9, and Bcl-2. Cancer Biol Ther 17, 169–180, 2016.10.1080/15384047.2015.1121346484800026618552
- Hacker KE, Bolland DE, Tan L, Saha AK, Niknafs YS, Markovitz DM, McLean K. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival. Neoplasia 20, 1209–1218, 2018.10.1016/j.neo.2018.10.005622662530412857
- Hesari Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, Alipour M, Tavakoli-Yaraki M, Ghorbanhosseini SS, Yousefi Z, Jafarzadeh M, Yarahmadi S. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells. Gene 673, 149–158, 2018.10.1016/j.gene.2018.06.02129886033
- Hu Y, Jin R, Gao M, Xu H, Zou S, Li X, Xing C, Wang Q, Wang H, Feng J, Hu M, Song L. Transcriptional repression of IKKbeta by p53 in arsenite-induced GADD45alpha accumulation and apoptosis. Oncogene 38, 731–746, 2019.10.1038/s41388-018-0478-7635565030177839
- Huang YQ, Han ZD, Liang YX, Lin ZY, Ling XH, Fu X, Cai C, Bi XC, Dai QS, Chen JH, He HC, Chen YR, Jiang FN, Zhong WD. Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer. Med Oncol 31, 820, 2014.10.1007/s12032-013-0820-424338276
- Hutschenreuther A, Bigl M, Hemdan NY, Debebe T, Gaunitz F, Birkenmeier G. Modulation of GLO1 expression affects malignant properties of cells. Int J Mol Sci 17, pii: E2133, 2016.10.3390/ijms17122133518793327999356
- Kim HG, Woo SU, Kim HY, Son GS, Lee JB, Bae JW, Woo OH, Yang DS, Seo JH, Kim AR. The expression of insulin receptor substrate 1 and estrogen receptor as prognostic factor on breast cancer patient. J Cancer Res Ther 14 (Supplement), S494–S498, 2018.10.4103/0973-1482.18118029970713
- Kruthika BS, Sugur H, Nandaki K, Arimappamagan A, Paturu K, Santosh V. Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma. J Clin Pathol 72, 677–681, 2019.10.1136/jclinpath-2019-20583431270134
- Lee BC, Song J, Lee A, Cho D, Kim TS. Visfatin promotes wound healing through the activation of ERK1/2 and JNK1/2 pathway. Int J Mol Sci 19, E3642, 2018.10.3390/ijms19113642627480930463229
- Li XS, Xu Q, Fu XY, Luo WS. Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer. J Cancer Res Clin Oncol 140, 1305–1313, 2014.10.1007/s00432-014-1698-z24804817
- Li Z, Qiu HY, Jiao Y, Cen JN, Fu CM, Hu SY, Zhu MQ, Wu DP, Qi XF. Growth and differentiation effects of Homer3 on a leukemia cell line. Asian Pac J Cancer Prev 14, 2525–2528, 2013.10.7314/APJCP.2013.14.4.2525
- Li Z, Levine KM, Bahreini A, Wang P, Chu D, Park BH, Oesterreich S, Lee AV. Upregulation of IRS1 enhances IGF1 response in Y537S and D538G ESR1 mutant breast cancer cells. Endocrinology 159, 285–296, 2018.10.1210/en.2017-00693576160229029116
- Liang N, Chen Y, Yang L, He S, Liu T. Visfatin increases miR-21 to promote migration in HCC. Cell Mol Biol (Noisy-le-grand) 64, 48–52, 2018.10.14715/cmb/2018.64.6.9
- Meram AT, Alzubaidi Y, Cotelingam J, Ghali G, Lopez L, Coppola D, Shackelford R. Nicotinamide phosphoribosyl transferase is increased in osteosarcomas and chondrosarcomas compared to benign bone and cartilage. Anticancer Res 39, 1761–1765, 2019.10.21873/anticanres.13282777130830952715
- Minchenko DO, Kharkova AP, Hubenia OV, Minchenko OH. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRAD, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and gluta-mine or glucose deprivation. Endocr Reg 47, 15–26, 2013.10.4149/endo_2013_01_1523363253
- Minchenko OH, Tsymbal DO, Minchenko DO, Moenner M, Kovalevska OV, Lypova NM. Inhibition of kinase and endoribonuclease activity of ERN1/IRE1 affects expression of proliferation-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 2, 18–29, 2015.10.1515/ersc-2015-0002
- Minchenko DO, Kharkova AP, Halkin OV, Karbovskyi LL, Minchenko OH. Effect of hypoxia on the expression of genes encoded insulin-like growth factors and some related proteins in U87 glioma cells without IRE1 function. Endocr Reg 50, 43–54, 2016a.10.1515/enr-2016-000827560636
- Minchenko DO, Riabovol OO, Tsymbal DO, Ratushna OO, Minchenko OH. Inhibition of IRE1 affects the expression of genes encoded glucocorticoid receptor and some related factors and their hypoxic regulation in U87 glioma cells. Endocr Reg 50, 127–136, 2016b.10.1515/enr-2016-001427560795
- Minchenko DO, Riabovol OO, Ratushna OO, Minchenko OH. Hypoxic regulation of the expression of genes encoded estrogen related proteins in U87 glioma cells: effect of IRE1 inhibition. Endocr Reg 51, 8–19, 2017.10.1515/enr-2017-000228222026
- Minchenko DO, Tsymbal DO, Luzina OY, Riabovol OO, Danilovskyi SV, Minchenko OH. Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells. Endocr Reg 54, 31–42, 2020.10.2478/enr-2020-000532597148
- Modem S, Chinnakannu K, Bai U, Reddy GP, Reddy TR. Hsp22 (HspB/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells. J Cell Physiol 226, 2747–2751, 2011.10.1002/jcp.22868317871521678403
- Nielsen KN, Peics J, Ma T, Karavaeva I, Dall M, Chubanava S, Basse AL, Dmytriyeva O, Treebak JT, Gerhart-Hines Z. NAMPT-mediated NAD+ biosynthesis is indispensable for adipose tissue plasticity and development of obesity. Mol Metab 11, 178–188, 2018.10.1016/j.molmet.2018.02.014600135529551635
- Nishiyama M, Wands JR. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma. Biochem Biophys Res Commun 183, 280–285, 1992.10.1016/0006-291X(92)91640-C
- Nivon M, Abou-Samra M, Richet E, Guyot B, Arrigo AP and Kretz-Remy C. NF-kappaB regulates protein quality control after heat stress through modulation of the BAG3-HspB8 complex. J Cell Sci 125, 1141–1151, 2012.10.1242/jcs.09104122302993
- Piccolella M, Crippa V, Cristofani R, Rusmini P, Galbiati M, Cicardi ME, Meroni M, Ferri N, Morelli FF, Carra S, Messi E, Poletti A. The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells. Oncotarget 8, 10400–10415, 2017.10.18632/oncotarget.14422535466728060751
- Qu M, Duffy T, Hirota T, Kay SA. Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks. Proc Natl Acad Sci USA 115, E12305–E12312, 2018.10.1073/pnas.1816411115631082130530698
- Rahman S, Kraljevic Pavelic S, Markova-Car E. Circadian (De)regulation in head and neck squamous cell carcinoma. Int J Mol Sci 20, pii: E2662, 2019.10.3390/ijms20112662660014331151182
- Shen J, Li M, Min L. HSPB8 promotes cancer cell growth by activating the ERKCREB pathway and is indicative of a poor prognosis in gastric cancer patients. Oncol Rep 39, 2978–2986, 2018.10.3892/or.2018.637629693129
- Shen TY, Mei LL, Qiu YT, Shi ZZ. Identification of candidate target genes of genomic aberrations in esophageal squamous cell carcinoma. Oncol Lett 12, 2956–2961, 2016.10.3892/ol.2016.4947503843927698883
- Shi C, Wu H, Du D, Im HJ, Zhang Y, Hu B, Chen H, Wang X, Liu Y, Cao P, Tian Y, Shen X, Gao R, van Wijnen AJ, Ye X, Yuan W. Nicotinamide phosphoribosyltransferase inhibitor APO866 prevents IL-1beta-induced human nucleus pulposus cell degeneration via autophagy. Cell Physiol Biochem 49, 2463–2482, 2018.10.1159/00049384330261504
- Smith CC, Lee KS, Li B, Laing JM, Hersl J, Shvartsbeyn M, Aurelian L. Restored expression of the atypical heat shock protein H11/HspB8 inhibits the growth of genetically diverse melanoma tumors through activation of novel TAK1-dependent death pathways. Cell Death Dis 3, E371, 2012.10.1038/cddis.2012.108343466622898869
- Sun Y, Zhou J, Shi L, Li J, Chen J. MicroRNA-466 inhibits cell proliferation and invasion in osteosarcoma by directly targeting insulin receptor substrate 1. Mol Med Rep 19, 3345–3352, 2019.10.3892/mmr.2019.995630816452
- Suzuki M, Matsushima-Nishiwaki R, Kuroyanagi G, Suzuki N, Takamatsu R, Furui T, Yoshimi N, Kozawa O, Morishige K. Regulation by heat shock protein 22 (HSPB8) of transforming growth factor-α-induced ovary cancer cell migration. Arch Biochem Biophys 571, 40–49, 2015.10.1016/j.abb.2015.02.03025731856
- Varlet AA, Fuchs M, Luthold C, Lambert H, Landry J, Lavoie JN. Fine-tuning of actin dynamics by the HSPB8-BAG3 chaperone complex facilitates cytokinesis and contributes to its impact on cell division. Cell Stress Chaperones 22, 553–567, 2017.10.1007/s12192-017-0780-2546503228275944
- Wang JH, Zhang L, Huang ST, Xu J, Zhou Y, Yu XJ, Luo RZ, Wen ZS, Jia WH, Zheng M. Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma. PLoS ONE 12, E0175280, 2017.10.1371/journal.pone.0175280538475428388691
- Wu L, Li Y, Li J, Ma D. MicroRNA-664 targets insulin receptor substrate 1 to suppress cell proliferation and invasion in breast cancer. Oncol Res 27, 459–467, 2019.10.3727/096504018X15193500663936784846729495974
- Xiang R, Cui Y, Wang Y, Xie T, Yang X, Wang Z, Li J, Li Q. Circadian clock gene Per2 downregulation in nonsmall cell lung cancer is associated with tumour progression and metastasis. Oncol Rep 40, 3040–3048, 2018.10.3892/or.2018.670430226549
- Xie Z, Chooi JY, Toh SHM, Yang D, Basri NB, Ho YS, Chng WJ. MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells. Leukemia 33, 739–748, 2019.10.1038/s41375-018-0300-030470837
- Xiong H, Yang Y, Yang K, Zhao D, Tang H, Ran X. Loss of the clock gene PER2 is associated with cancer development and altered expression of important tumor-related genes in oral cancer. Int J Oncol 52, 279–287, 2018.10.3892/ijo.2017.418029115399
- Xu H, Lee MS, Tsai PY, Adler AS, Curry NL, Challa S, Freinkman E, Hitchcock DS, Copps KD, White MF, Bronson RT, Marcotrigiano M, Wu Y, Clish CB, Kalaany NY. Ablation of insulin receptor substrates 1 and 2 suppresses Kras-driven lung tumorigenesis. Proc Natl Acad Sci USA 115, 4228–4233, 2018.10.1073/pnas.1718414115591083729610318
- Xu R, Yuan Z, Yang L, Li L, Li D, Lv C. Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress. Oncol Rep 38, 1767–1773, 2017.10.3892/or.2017.579328714034
- Yoneyama Y, Lanzerstorfer P, Niwa H, Umehara T, Shibano T, Yokoyama S, Chida K, Weghuber J, Hakuno F, Takahashi SI. IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling. Elife 7, pii: e32893, 2018.10.7554/eLife.32893590386629661273
- Yoo JJ, Yu SJ, Na J, Kim K, Cho YY, Lee YB, Cho EJ, Lee JH, Kim YJ, Youn H, Yoon JH. Hexokinase-II inhibition synergistically augments the anti-tumor efficacy of sorafenib in hepatocellular carcinoma Int J Mol Sci 20, E1292, 2019.10.3390/ijms20061292647130230875800
- You S, Guan Y, Li W. Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. Mol Med Rep 17, 1065–1070, 2018.10.3892/mmr.2017.794329115492
- Zhao H, Tang W, Chen X, Wang S, Wang X, Xu H, Li L. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells. Biochem Biophys Res Commun 493, 77–84, 2017.10.1016/j.bbrc.2017.09.07128919418
- Zhou Y, Leng X, He Y, Li Y, Liu Y, Liu Y, Zou Q, Shi G, Wang Y. Loss of Perp in T cells promotes resistance to apoptosis of T helper 17 cells and exacerbates the development of experimental autoimmune encephalomyelitis in mice. Front Immunol 9, 842, 2018.10.3389/fimmu.2018.00842592596029740445